[Webinar held on 5/17] <Peaceful compliance measures commentary series 2nd> Site of whistleblowing response
Today, how to ensure the effectiveness of the whistleblowing system is one of the most annoying challenges for many companies.In addition, with the imminent enforcement of the revised Whistleblower Protection Act, which includes the obligation to improve the whistleblower system, many companies may be busy with the operation of the new whistleblower system.
Therefore, this time, we would like to invite Mr. Daisuke Fukamizu, a partner of Nagashima Ohno & Tsunematsu Law Office, to introduce several important issues that are frequently faced in the field of dealing with whistleblowing cases.Furthermore, in the lecture, you will be asked to consider and explain important issues from the practical point of view of Attorney Fukamizu.
* This seminar is the second in a series of three seminars in which Mr. Fukamizu, a lawyer from Nagashima Ohno & Tsunematsu Law Office, explains peacetime compliance measures. Even those who have not attended the first lecture can participate, so please apply.
◆ Title: <Peaceful Compliance Measures Explanation Series 2nd> Site for whistleblowing
◆ Date: July 2022, 5 (Tuesday) 17: 10-00: 11
◆ Webinar type: Zoom Webinar
ALB under 40 Asia Outstanding Legal Professionals 40 (2019)
LEGAL 500 ASIA PACIFIC NEXT GENERATION Lawyers (2020)
Alb Young Lawyer of the Year (2020)
FRONTEO Inc. Director / AI Solution Business Management and President's Office Manager
Mari Yamamoto
After joining an advertising agency, she was enrolled in a risk management company.Launch the mental health care business, execute business plans, product development, marketing, and sales strategies, and lead to the top market share in the industry. In 2014, she became a director of the company and was listed on the First Section of the Tokyo Stock Exchange in 2017.
Joined FRONTEO Inc. in December 2018 and became a director in 12, managing and directing the entire AI solution business.
In the life science AI business, we will promote development in the digital health field such as diagnostic support and disease prediction using the artificial intelligence engine "Concept Encoder", and also in the drug discovery field, a drug discovery support AI system that supports speeding up the discovery of candidate compounds. To challenge new areas in life science.
In the business intelligence business, he uses the artificial intelligence engine "KIBIT" to direct the DX promotion of companies.We will also develop solutions that utilize AI in the field of economic security to support governments, government agencies, and companies.
Articles in the same category
[5/31 15th Fraud Countermeasures Study Session] [Must-see for compliance personnel] Mass media response in the event of a crisis
[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -
[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Searching for therapeutic targets for pancreatic cancer - I tried using paper search AI -
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI
[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response
